Search hospitals > Illinois > Chicago

University of Illinois Cancer Center

Claim this profile
Chicago, Illinois 60612
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lymphoma
Conducts research for Non-Small Cell Lung Cancer
118 reported clinical trials
16 medical researchers
Photo of University of Illinois Cancer Center in ChicagoPhoto of University of Illinois Cancer Center in ChicagoPhoto of University of Illinois Cancer Center in Chicago

Summary

University of Illinois Cancer Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Non-Small Cell Lung Cancer and other specialties. University of Illinois Cancer Center is involved with conducting 118 clinical trials across 151 conditions. There are 16 research doctors associated with this hospital, such as Lawrence E. Feldman, Shikha Jain, Paul Rubinstein, MD, and Oana Danciu.

Area of expertise

1Lung Cancer
Global Leader
University of Illinois Cancer Center has run 21 trials for Lung Cancer. Some of their research focus areas include:
HER2 positive
Stage IV
Stage III
2Breast Cancer
Global Leader
University of Illinois Cancer Center has run 19 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
HER2 positive
Stage III

Top PIs

Clinical Trials running at University of Illinois Cancer Center

Breast Cancer
Lung Cancer
Lymphoma
Thyroid Cancer
Ovarian Cancer
Multiple Myeloma
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
Small Cell Lung Cancer
Relapse
Image of trial facility.

Low Dose Azacitidine

for Early Stage Breast Cancer

This trial is testing if low dose azacitidine can help the immune system fight high-risk early stage breast cancer. The treatment aims to increase immune cells that attack cancer cells. It targets patients whose cancer is more likely to return or spread.
Recruiting1 award Phase 210 criteria
Image of trial facility.

BL-M07D1

for HER2-Positive Cancer

The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-M07D1 in patients with HER2 expressing advanced tumors.
Recruiting1 award Phase 1
Image of trial facility.

Alisertib + Endocrine Therapy

for Breast Cancer

PUMA-ALI-1201 is a randomized, dose optimization, multicenter, Phase 2 study of alisertib administered in combination with endocrine therapy in participants with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two prior lines of endocrine therapy in the recurrent or metastatic setting. This study is intended to evaluate the optimal alisertib dose administered in combination with the selected endocrine therapy. The study is also planned to evaluate the efficacy, safety, and pharmacokinetics of alisertib in combination with endocrine and to identify the biomarker-defined subgroup(s) that may benefit most from combined alisertib and endocrine therapy.
Recruiting1 award Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at University of Illinois Cancer Center?
University of Illinois Cancer Center is a medical facility located in Chicago, Illinois. This center is recognized for care of Lung Cancer, Breast Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lymphoma, Non-Small Cell Lung Cancer and other specialties. University of Illinois Cancer Center is involved with conducting 118 clinical trials across 151 conditions. There are 16 research doctors associated with this hospital, such as Lawrence E. Feldman, Shikha Jain, Paul Rubinstein, MD, and Oana Danciu.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security